EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
149 hedge funds and large institutions have $1.31B invested in Eagle Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+12
Holders Change %
+8.76%
% of All Funds
3.73%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.15%
New
31
Increased
48
Reduced
46
Closed
16
Calls
$20.7M
Puts
$18.4M
Net Calls
+$2.23M
Net Calls Change
-$8.96M
Top Buyers
Top Sellers
1 |
PAI
ProQuest Associates IV
Naples,
Florida
|
-$34.2M |
2 |
O
OrbiMed
New York
|
-$29M |
3 |
PC
PointState Capital
New York
|
-$21.3M |
4 |
Morgan Stanley
New York
|
-$9.54M |
5 |
JCI
Jet Capital Investors
New York
|
-$9.44M |